Xconomy

JUNE 8, 2018

Teradata (NYSE: TDC ), a specialist in data warehousing, business analytics, and consulting services, disclosed this week that it plans to move its corporate headquarters from Dayton, OH, to San Diego by the end of the year. The move is part of a broader corporate consolidation, according to a June 6 regulatory filing. According to.

San Diego 59

San Diego Research Services Cloud Computing 59

Xconomy

AUGUST 31, 2016

Roger Tsien, a UC San Diego scientist who shared the 2008 Nobel Prize in chemistry for research that led to the development of fluorescent proteins used to illuminate tissue and track biological processes, has died, according to a statement from the university. He compared himself to John C.

San Diego 72

San Diego UCSD Avalon Study 72

Xconomy

JUNE 23, 2016

The center commissioned the report to help quantify the economic impact of the cybersecurity industry in San Diego, and to assess how employers view their prospects for growth and needs for future hiring. The center also asked the San Diego Regional Economic Development Corp. That represents a 9.5

San Diego 69

San Diego Study Outsource Development Report 69

Xconomy

SEPTEMBER 10, 2019

Fall is finally arriving, as indicated by the recent shortened work week, and few may object given the unseasonably hot, muggy weather San Diego has been experiencing recently. Track down somewhere with AC, then catch up on recent developments in the local life sciences scene.

San Diego 46

San Diego Capital Develop Development 46

Xconomy

JUNE 21, 2016

Six San Diego business risk-takers have been inducted into the pantheon of EY Entrepreneurs of the Year, joining over 10,000 people around the world who have been honored over the last 30 years by the multinational professional services firm. The winners are: — Life Sciences: BioLegend CEO Gene Lay.

San Diego 57

San Diego Entrepreneur Startup Mobile 57

Xconomy

SEPTEMBER 21, 2018

San Antonio — Life science groups, city officials, and research institutes in San Antonio are organizing an effort to commercialize more scientific developments coming out of the city’s military organizations. Read more » Reprints | Share: UNDERWRITERS AND PARTNERS.

Research 78

Research Organization Develop Development 78

Xconomy

MAY 3, 2017

He continued his research on tumor vasculature and cancer metastasis. Now 77, Ruoslahti (pictured above) is back in San Diego as a founder and CEO of DrugCendR , a startup developing new ways to improve the uptake of anti-cancer drugs in solid tumors. The company spun out of the SBP.

San Diego 45

San Diego Santa Barbara Research Startup 45

Xconomy

APRIL 7, 2020

Inovio Pharmaceuticals, one of the biotechs developing a vaccine to prevent COVID-19, has received the FDA’s OK to start testing its candidate in healthy volunteers. The Plymouth Meeting, PA-based company, which also conducts research in San Diego, plans to enroll as many as 40 adults across two trial locations.

San Diego 108

San Diego Study Research Develop 108

Xconomy

JANUARY 3, 2018

Xconomy asked technology and innovation leaders around our network to reflect on the most important developments in their industries during 2017, and the answers were appropriately wide-ranging. Here now are responses, edited for clarity, from Mark Bowles, co-founder of medical diagnostics. Read more » Reprints | Share:

Artificial Inteligence 68

Artificial Inteligence Develop Development Social Media 68

Xconomy

MARCH 25, 2019

A program launched last year by the Wisconsin Alumni Research Foundation to invest in promising biotech discoveries made on the University of Wisconsin-Madison campus will also work with the La Jolla, CA-based Sanford Burnham Prebys Medical Discovery Institute, the organizations said recently.

San Diego 107

San Diego Research Organization Invest 107

Xconomy

MARCH 28, 2019

million from new investors, including the New York-based Juvenile Diabetes Research Foundation, following the results of a clinical study of its experimental biomarker monitoring device. Founders Jared Tagney and Joshua Windmiller, who met while in grad school at UC San Diego, started the company in 2012 as Electrozyme.

San Diego 103

San Diego Study Research Design 103

Xconomy

AUGUST 11, 2020

San Diego-based Ligand (NASDAQ: LGND ) generates revenue from licensing deals and royalties paid by pharmaceutical companies that use technologies it develops or acquires for their own drug research. The company reported revenues of about $120.3 million in 2019.

San Diego 98

San Diego Technology Research Pricing 98

Xconomy

APRIL 21, 2020

. “ Decentralized Clinical Trials: The Call for a New Paradigm ” and “ Sustaining Clinical Research During the Crisis ” offer the latest trends and technologies companies can use to keep business running as smooth as possible.

Research 58

Research Report Technology Develop 58

Xconomy

DECEMBER 10, 2019

The Scripps Research Institute and AbbVie have agreed to broaden an existing drug discovery agreement focused on cancer cell therapies to now encompass treatments for other kinds of disease. Financial terms of this latest agreement weren’t disclosed, but the deal expands the purview. Read more » Reprints | Share:

Research 52

Research Study Design Organization 52

Xconomy

NOVEMBER 8, 2018

Dozens of research institutes. San Diego is one of the top U.S. Researchers and entrepreneurs here are leaders in developing the next generation of medicines and medical devices. Hundreds of companies. Billions of dollars in economic impact. cities for innovation in life sciences and healthtech.

San Diego 82

San Diego Research Tool Entrepreneur 82

Xconomy

FEBRUARY 12, 2020

San Diego-based Ligand (NASDAQ: LGND ) is paying $15 million up front for the “core assets” of Icagen’s North Carolina operations. The neuroscience program is being developed under a partnership with Roche while the cystic fibrosis research is a collaboration with the Cystic Fibrosis Foundation.

San Diego 93

San Diego Research Develop Development 93

Xconomy

MAY 18, 2017

Preliminary findings from an economic impact study show that genomics is emerging as a distinct innovation cluster in San Diego. The San Diego Regional Economic Development Corp. began collecting data for the report earlier this year in a bid to assess how genomics fits into San Diego’s innovation economy.

Study 97

Study San Diego Venture Capital Press 97

Xconomy

FEBRUARY 6, 2020

This is the last week to register at the lowest rate for March 18’s Xcelerating Life Sciences: Biomedical Breakthroughs in Precision Medicine & Genomics conference at the Takeda Research facility in San Diego. Hurry, our $99 early bird sale ends this Friday, Feb. 7 at midnight. Speakers include Jay Lichter, CEO of.

Conference 49

Conference San Diego Sales Research 49

Xconomy

AUGUST 7, 2019

Organovo says it has run out of money to advance its efforts to develop 3-D “patches” of living human liver tissue to tide over people waiting for an organ transplant. In the meantime, the company built a business as a contract research organization around its 3-D human tissue cultures, which pharma companies have used.

San Diego 90

San Diego Outsource Development Organization Research 90

Xconomy

JUNE 14, 2018

New immunotherapy approaches to cancer treatment, and the CRISPR technology for editing genetic material in cells, are among the most sophisticated research strategies scientists are using in their quest to defeat disease.

Research 74

Research Software Engineering Software Technology 74

Xconomy

APRIL 24, 2019

Forge Therapeutics, founded in 2015 with the goal of developing drugs that target metalloenzymes, said Wednesday it had agreed to let Basilea Pharmaceutica use its chemistry platform to develop new antibiotics. Basilea is also developing oncology drugs. The San Diego.

San Diego 79

San Diego Research Platform Develop 79

Xconomy

OCTOBER 15, 2018

Reflexion Health, which has developed a “virtual physical therapy” system for patients recovering from surgery, said results from a randomized controlled clinical trial completed by nearly 300 people showed patients who used the technology saved an average of $2,745 compared to those who underwent traditional physical therapy.

Study 83

Study San Diego Research Startup 83

Xconomy

OCTOBER 1, 2018

VelosBio, a biotech startup researching new cancer drugs, has raised $58 million in financing. VelosBio joined Johnson & Johnson’s JLABS @ San Diego incubator in January. The company is developing antibody drug conjugates, a class of cancer drug that links antibodies to potent cancer-fighting toxins.

San Diego 91

San Diego Incubator Class Study 91

Xconomy

JUNE 19, 2019

Now a former director from the company is leading a startup that has raised $15 million to develop new genome sequencing tools. San Diego’s Element Biosciences said Tuesday that it had secured a Series A round led by Foresite Capital, a healthcare and life sciences venture capital firm based in San Francisco, and Silicon Valley’s Venrock.

Tool 67

Tool Develop Development Venture Capital 67

Xconomy

NOVEMBER 19, 2018

Cibus, which has developed a proprietary gene-editing technology that tweaks crops’ DNA to improve yield, is planning to make its public market debut. The San Diego-based biotech set a preliminary $100 million target for its IPO in documents filed with securities regulators Friday.

San Diego 72

San Diego Research Startup Pricing 72

Xconomy

FEBRUARY 6, 2020

Scripps Research is charting new territory with its Calibr division, a drug discovery and drug development group within the research institute that is advancing its own experimental treatments.

Research 116

Research Develop Development San Diego 116

Xconomy

FEBRUARY 15, 2017

Liver disease is challenging for doctors because it can develop without symptoms, making diagnosis difficult without removing cells for examination. For these reasons, fatty liver disease is often called a “silent disease,” says Ariel Feldstein, a gastroenterologist at the University of California San Diego.

UCSD 64

UCSD Press San Diego Class 64

Xconomy

JUNE 27, 2018

Sales of Cibus’ first product, a gene-edited canola, have gone so well that the San Diego company has raised $70 million in new financing to boost its commercialization efforts. Cibus’s first commercial product is SU Canola, a variety of canola that is tolerant to sulfonylurea, a type of herbicide.

San Diego 61

San Diego Marketing Research Invest 61

Xconomy

JUNE 10, 2018

CureMatch , a San Diego startup with technology to help doctors choose the best combination of anti-cancer treatments based on an analysis of each patient’s tumor, took home a $35,000 grant intended to help companies expand overseas. CureMatch was the top vote-getter among four finalists that.

San Diego 72

San Diego Startup Organization Help 72

Xconomy

OCTOBER 13, 2017

The idea in 2011 was to create a space at what was then Johnson & Johnson’s pharmaceutical research and development facility in San Diego for an “innovation center,” a place where 18 to 20 life sciences startups could incubate, replete with lab space and equipment.

San Diego 75

San Diego Incubator Screening Research 75

Xconomy

JANUARY 11, 2020

The San Diego-based drug developer last month struck a deal with Xenon Pharmaceuticals (NASDAQ: XENE ) that added an experimental treatment for a rare, hereditary form of early-onset epilepsy to its pipeline. Now the San Diego-based drug developer has struck a partnership with Swiss biotech Idorsia.

San Diego 63

San Diego Develop Development Company 63

Xconomy

MAY 30, 2017

San Diego-based Arcturus Therapeutics said today Cystic Fibrosis Foundation Therapeutics has agreed to provide $3 million to fund research and development of a new messenger RNA drug that could be broadly used to treat cystic fibrosis patients. Arcturus says its technology can be used to make.

Arcturus 65

Arcturus San Diego Research Funding 65

Xconomy

SEPTEMBER 6, 2017

A top prize in American biomedical science was awarded today to two scientists for their discoveries that led to the development of a human papillomavirus (HPV) vaccine, which prevents cervical cancer caused by the sexually transmitted virus. Read more » Reprints | Share: UNDERWRITERS AND PARTNERS.

Develop 55

Develop Development Research San Diego 55

Xconomy

OCTOBER 23, 2017

Things have been moving quickly in recent weeks for the San Diego RNA drug developer Arcturus Therapeutics. After initiating a reverse merger last month, Arcturus signed a research collaboration and worldwide licensing agreement with Janssen Pharmaceuticals, part of the Johnson & Johnson (NYSE: JNJ ) family of companies.

Arcturus 65

Arcturus San Diego Research Develop 65

Xconomy

MARCH 7, 2019

Chinese pharma company BeiGene has agreed to pay Ambrx $10 million upfront to experiment with technology the biotech has developed in a bid accelerate BeiGene’s search for new protein drugs for cancer treatment. Ambrx says its technology is able to incorporate “non-natural” amino acids into cells like E.

Develop 79

Develop Development Technology Product 79

Xconomy

OCTOBER 1, 2019

Biologists have been using artificially created DNA, produced through what’s known as chemical DNA synthesis, as a research tool for decades. Now, as demand for engineered DNA rises, a handful of startups are vying to become the go-to provider for researchers looking for improved versions of the DNA sequences.

San Diego 43

San Diego Research Writing Demand 43

Xconomy

SEPTEMBER 19, 2019

The San Diego-based biotech came out of stealth mode Thursday with an announcement that it had raised a $46.4 million Series A financing round to fund the development of cancer drugs targeting tumors that have what’s known as extrachromosomal DNA. Zach Hornby, former chief.

San Diego 102

San Diego Funding Develop Development 102